UK Markets open in 3 hrs 23 mins
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • CRUDE OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • BTC-GBP

    23,288.35
    -794.11 (-3.30%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • Nasdaq

    11,354.62
    -33.88 (-0.30%)
     
  • ^FTAS

    4,083.84
    +44.90 (+1.11%)
     

Global Sleep Apnea Diagnostics Market Report to 2030 - Opportunity Analysis and Industry Forecasts

·7-min read
Company Logo
Company Logo

Global Sleep Apnea Diagnostics Market

Global Sleep Apnea Diagnostics Market
Global Sleep Apnea Diagnostics Market

Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Sleep Apnea Diagnostics Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global sleep apnea diagnostics market was valued at $290.50 million in 2020, and is projected to reach $545.09 million by 2030, registering a CAGR of 6.7% from 2021 to 2030.

Obstructive sleep-disordered breathing (SDB) is a syndrome of upper airway dysfunction during sleep that is characterized by snoring and/or increased respiratory effort secondary to greater upper airway resistance and pharyngeal collapsibility. Obstructive sleep apnea (OSA) is a sleep disorder that results in significant decrease or cessation of airflow in the presence of breathing effort. If the brain does not send the signals needed to breathe, the condition is referred to as central sleep apnea. Around 85-90% of OSA patients are estimated to remain undiagnosed that demonstrates the unmet medical needs. Sleep apnea diagnostic products evaluate the breathing and other body functions of patients during sleep, thereby boosting the demand for these devices to combat sleep apnea disease.

The general characteristic of Obstructive Sleep Apnea is the increased collapsibility of the upper airway during sleep resulting in markedly reduced (hypopnea) or absent (apnea) airflow at the nose and/or mouth which is usually accompanied by oxyhemoglobin desaturation and is typically terminated by a brief micro-arousal. Repeated episodes of apnea lead to a sustained reduction in oxyhemoglobin saturation and sleep fragmentation with diminished amounts of slow-wave and rapid eye movement (REM) sleep. The major predisposing factor for sleep apnea is excess body weight. It has been estimated that 58% of moderate to severe OSA is attributable to obesity.

The global sleep apnea diagnostic market is anticipated to register notable growth due to increase in geriatric population as well as a surge in prevalence of sedentary lifestyle disorders such as obesity and diabetes, as well as considerable increase in awareness about sleep apnea. Furthermore, technical developments to make products more convenient for users as well as a notable increase in sleep apnea diseases are driving market expansion. However, the market is expected to be hampered by the high cost of sleep apnea treatment tools, restricted reimbursement for these devices, and low patient compliance. On the contrary, the progressive rise in popularity of home healthcare equipment is expected to provide attractive development opportunities for the global market in the near future.

The global sleep apnea diagnostics market is segmented into product, end user, and region. Depending on product, the market is fragmented into polysomnography (PSG) devices, actigraphy systems, respiratory polygraph, sleep apnea screening device, oximeter, and others. On the basis of end user, it is bifurcated into sleep laboratory & hospital and home healthcare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.

  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

  • A comprehensive analysis of the factors that drive and restrain the growth of the sleep apnea diagnostics market is provided.

  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top winning strategies, by year, 2019-2021
3.2.4. Top winning strategies, by developments, 2019-2021(%).
3.2.5. Top winning strategies, by company, 2019-2021.
3.2.6. Top player positioning, 2020
3.3. Porter's five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of obesity across the globe
3.4.1.2. Increase in number of employees working in shifts and under stressful work conditions
3.4.1.3. Technological advancements in sleep apnea diagnostic devices
3.4.2. Restraints
3.4.2.1. High cost associated with sleep apnea diagnostic devices
3.4.2.2. Lack of awareness among patients regarding sleep apnea
3.4.3. Opportunity
3.4.3.1. Untapped markets in developing economies
3.5. COVID-19 impact analysis on sleep apnea diagnostics market

CHAPTER 4: SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Polysomnography device (PSG)
4.2.1. Key trends and opportunities
4.2.2. List of distributors
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.2.5. Clinical PSG
4.2.5.1.1. Market size and forecast
4.2.6. Ambulatory PSG
4.2.6.1.1. Market size and forecast
4.3. Sleep apnea screening device
4.3.1. Key trends and opportunities
4.3.2. List of ditributors
4.3.3. Market size and forecast
4.3.4. Market analysis, by country
4.4. Actigraphy monitoring device
4.4.1. Key trends and opportunities
4.4.2. List of distributors
4.4.3. Market size and forecast
4.4.4. Market analysis, by country
4.5. Respiratory polygraph
4.5.1. Key trends and opportunities
4.5.2. List of distributors
4.5.3. Market size and forecast
4.5.4. Market analysis, by country
4.6. Oximeter
4.6.1. Key trends and opportunities
4.6.2. List of distributors
4.6.3. Market size and forecast, by region
4.6.4. Market analysis, by country
4.6.5. Fingertip oximeter
4.6.5.1.1. Market size and forecast
4.6.6. Handheld oximeter
4.6.6.1.1. Market size and forecast
4.6.7. Wrist-worn oximeter
4.6.7.1.1. Market size and forecast
4.6.8. Tabletop oximeter
4.6.8.1.1. Market size and forecast

CHAPTER 5: SLEEP APNEA DIAGNOSTICS MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals & sleep laboratories
5.2.1. List of distributors
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Home care settings
5.3.1. List of distributors
5.3.2. Market size and forecast
5.3.3. Market analysis, by country

CHAPTER 6: SLEEP APNEA DIAGNOSTICS MARKET, BY REGION

CHAPTER 7: COMPANY PROFILES
7.1. Cadwell Industries Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Devilbiss Healthcare
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. Koninklijke Philips N.V. (Philips)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. Medtronic Plc.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segment
7.4.4. Product portfolio
7.4.5. Business performance
7.5. Mindray Medical International Limited
7.5.1. Company overview
7.5.2. Operating business segment
7.5.3. Product portfolio
7.6. Natus Medical Incorporated
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Nihon Kohden Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Resmed Inc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segment
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Smith's Group Plc. (Smiths Medical)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. SOMNOmedics Gmbh
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance

For more information about this report visit https://www.researchandmarkets.com/r/cdj306

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting